Oyster Bay, New York - 04 Sep 2014
Close to 100 million wearable remote patient monitoring (RPM) devices will ship over the next 5 years, according to ABI Research, boosted by growing interest and awareness about the benefits of supporting healthcare away from the hospital and into patients’ homes. A key part of the emerging opportunity is the ability to collect data from a variety of vendor devices and sharing it securely with a range of related parties including patients, healthcare providers, and payers.The last six months alone have seen consumer brand giants Apple, Google, and Samsung all set out plans to provide RPM services.
RPM offers the promise of greater care and flexibility for patients while bringing efficiency and cost savings to health service providers. However, adoption has been stymied by a range of factors including device availability, device and service regulation, inertia and a high barrier to entry for new players in the space.
“Data has traditionally resided in silos belonging to specific applications delivered primarily by device vendors themselves. New cloud platforms capable of collecting data from a range of vendor devices and sharing it securely with a range of related parties including patients, healthcare providers, and payers will drive adoption and bring more connected devices to market,” comments Jonathan Collins, principal analyst at ABI Research.
Consumers are playing a role in the adoption of RPM as well. Already aware of activity tracking with wearable wireless devices from players like FitBit and Jawbone, some patients are looking for the same functionality from medical devices. In the continuous glucose monitoring market, devices from Dexcom, Animas, Medtronic, and others use wearable wireless technology to provide customers with connected ways to manage their condition as well as track and share details of their experience with their healthcare providers. Wireless connectivity is increasingly embedded in pulse oximeters, blood pressure cuffs, ECG monitors, and a host of emerging devices focused on specific health conditions and body parameters.
The latest ABI research report, “The Remote Patient Management Revolution: Wearable Devices and Open Management Platforms”, looks at the key devices, platforms and market drivers and inhibitors in the RPM market as well as forecasts device adoption over the next 5 years. The report is part of ABI research’s mHealth Wearables, Platforms and Services Market Research.
ABI Research provides in-depth analysis and quantitative forecasting of trends in global connectivity and other emerging technologies. From offices in North America, Europe and Asia, ABI Research’s worldwide team of experts advises thousands of decision makers through 70+ research and advisory services. Est. 1990. For more information visit www.abiresearch.com, or call +1.516.624.2500.
About ABI Research
ABI Research provides strategic guidance to visionaries, delivering actionable intelligence on the transformative technologies that are dramatically reshaping industries, economies, and workforces across the world. ABI Research's global team of analysts publish groundbreaking studies often years ahead of other technology advisory firms, empowering our clients to stay ahead of their markets and their competitors.
ABI Research提供开创性的研究和战略指导，帮助客户了解日新月异的技术。 自1990年以来，我们已与全球数百个领先的技术品牌，尖端公司，具有远见的政府机构以及创新的贸易团体建立了合作关系。 我们帮助客户创造真实的业务成果。
For more information about ABI Research's services, contact us at +1.516.624.2500 in the Americas, +44.203.326.0140 in Europe, +65.6592.0290 in Asia-Pacific or visit www.abiresearch.com.
Asia: +65 6950.5670